RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Carrie House to Xenograft Model Antitumor Assays

Back to Details
This is a "connection" page, showing publications Carrie House has written about Xenograft Model Antitumor Assays.
Carrie House
Connection Strength
0.312
Xenograft Model Antitumor Assays
  1. Cruz LS, Robinson M, Stevenson D, Amador IC, Jordan GJ, Valencia S, Navarrete C, House CD. Chemotherapy Enriches for Proinflammatory Macrophage Phenotypes that Support Cancer Stem-Like Cells and Disease Progression in Ovarian Cancer. Cancer Res Commun. 2024 10 01; 4(10):2638-2652.
    View in: PubMed
    Score: 0.200
  2. Hernandez L, Kim MK, Lyle LT, Bunch KP, House CD, Ning F, Noonan AM, Annunziata CM. Characterization of ovarian cancer cell lines as in vivo models for preclinical studies. Gynecol Oncol. 2016 08; 142(2):332-40.
    View in: PubMed
    Score: 0.112
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support